Mainland China

HZICC:From service to ecosystem: Hangzhou is rising as a talent magnet

HANGZHOU, China, Nov. 28, 2025 /PRNewswire/ -- In the global landscape of innovation and entrepreneurship, Hangzhou is emerging as the destination of choice for a growing number of high-level overseas talents, thanks to its distinctive policy advantages, comprehensive service system, and favorabl...

2025-11-28 21:06 866

BioDlink Showcases Europe-China CMC Collaboration Amid Developmental Breakthrough

* Recognized as Biologics CDMO of the Year, BioDlink shares insights into the world's first approved EGFR-targeted ADC for recurrent/metastatic nasopharyngeal carcinoma * The company enables seamless Europe–China tech transfer and faster biologics development through an integrated, end-to-end...

2025-11-28 21:00 1038

Angel Yeast's 8,500-Ton Specialty Yeast Facility and New Brewing Microbial Pilot Platform Come Online

YICHANG, China, Nov. 28, 2025 /PRNewswire/ -- Angel Yeast (SH600298), a global leader in yeast and fermentation solutions, has begun trial production at its new specialty yeast project in the Baiyang Biotechnology Park, Yichang High‑tech Zone. The facility commenced m...

2025-11-28 20:58 894

Shanghai Electric Launches Sino-Pakistan Academy of Excellence for Engineers to Cultivate "Belt and Road" Talent

Promoting industry-academia collaboration and Sino-Pakistan technological and cultural exchanges through interdisciplinary energy and electrical engineering education SHANGHAI, Nov. 28, 2025 /PRNewswire/ -- Shanghai Electric (SEHK: 2727, SSE: 601727) officially launched the Sino-Pakistan Acade...

2025-11-28 20:57 1202

Inaticabtagene Autoleucel (YORWIDATM) New Drug Application for Lymphoma Approved, China's innovative CAR-T Enters a New Era of Dual Indications

BEIJING, Nov. 28, 2025 /PRNewswire/ -- On November 28, 2025, Juventas Cell Therapy Co., Ltd. (hereinafter referred to as "Juventas") announced that its independently developed CAR-T cell therapy product, Inaticabtagene Autoleucel ( Ina-cel) (tradename: YORWIDATM), has received new drug marketing a...

2025-11-28 20:52 1003

Design Without Borders: Coohom Empowers a New Generation of Spatial Designers

HANGZHOU, China, Nov. 28, 2025 /PRNewswire/ -- Today, a technological shift is reshaping the industry. At the forefront is Coohoma product of Manycore Tech, a cloud-based AI design platform known for its speed, simplicity, and powerful collaborative tools. Designers worldwide—from award-winning v...

2025-11-28 19:28 1159

Tianlong Strengthens Transfusion Safety with Innovative Blood Screening Solutions on World AIDS Day 2025

XI'AN, China, Nov. 28, 2025 /PRNewswire/ -- On World AIDS Day 2025, Tianlong reiterates its commitment to advancing global transfusion safety by presenting its fully integrated nucleic acid blood screening solution. Combining high automation with high-sensitivity NAT reagents, the solution enable...

2025-11-28 18:33 1099

Xinhua Silk Road: Why UNESCO commends E. China's Wenzhou twice within just half a month?

BEIJING, Nov. 28, 2025 /PRNewswire/ -- Wenzhou city in east China's Zhejiang Province has been commended twice by the United Nations Educational, Scientific and Cultural Organization (UNESCO) recently for its practical achievements in cultural heritage preservation, cultural and tourism integrati...

2025-11-28 18:06 1444

Xinhua Silk Road: Shanghai's Minhang District showcases industrial strength at CIIE

BEIJING, Nov. 28, 2025 /PRNewswire/ -- During the recent China International Import Expo (CIIE), the reporter delivered on-camera coverage to offer an interpretive guide to the event.   By focusing on participating enterprises from Minhang District, Shanghai, and their achievements, the coverag...

2025-11-28 16:58 2102

International Communication Center of Guizhou Radio and Television Station: Preserving the Classics and Keeping Culture Alive

GUIYANG, China, Nov. 28, 2025 /PRNewswire/ -- During the the World Anti-Fascist War, invaders attempted to seize the Wenlan Pavillion copy of theSi Ku Quan Shu , or Complete Library in the Four Branches of Literature. To keep this monumental class...

2025-11-28 16:20 833

Huawei Digital Power's Full-Lifecycle BESS Safety Quantitative Assessment System Earns Top Appraisal

BEIJING, Nov. 28, 2025 /PRNewswire/ -- Huawei Digital Power, in collaboration with leading industry partners, has successfully passed a rigorous technical appraisal conducted by the China Electricity Council for the Full-Lifecycle BESS Safety Quantitative Assessment System. The appraisal committe...

2025-11-28 15:28 935

ACHA General Assembly in Chongqing Advances Cultural Heritage Protection

CHONGQING, China, Nov. 28, 2025 /PRNewswire/ -- A news report from iChongqing. On November 27th, the Second General Assembly and Third Council Meeting of the Alliance for Cultural Heritage inAsia (ACHA) convened in Chongqing, bringing together representatives from 33 countries and international ...

2025-11-28 14:30 987

iQIYI Extends Theatrical Film Value with Cross-Platform Success of "The Shadow's Edge"

BEIJING, Nov. 28, 2025 /PRNewswire/ -- Recently, iQIYI, China's leading online entertainment platform, announced the successful online release of its action-crime thriller "The Shadow's Edge", which quickly achieved top rankings and strong viewer engagement across both iQIYI and third-party chart...

2025-11-28 14:02 926

Weihai Receives National Award for Excellence in Accessibility Development

BEIJING, Nov. 28, 2025 /PRNewswire/ -- A news report from CRI Online: Weihai has been recognized as an "Outstanding Contributor in Accessibility and Age-Friendly Renovation" for its achievements in building an inclusive urban environment. The award was presented at the 23rd China International U...

2025-11-28 13:30 1333

JETOUR Partners with Discovery and CCF to Relaunch the "Return of the Cheetah"

WUHU, China, Nov. 28, 2025 /PRNewswire/ -- Following the global success of the environmental documentary Return of the Cheetah, JETOUR has once again joined hands with Discovery Channel and the Cheetah Conservation Fund (CCF) to relaunch the "Return of the Cheetah" initiative.

2025-11-28 13:07 944

Imugene and JW Therapeutics Announce a Collaboration to Advance onCARlytics and Carteyva® Combination in Solid Tumours

* Imugene and JW Therapeutics (Shanghai) Co., LTD have entered a strategic collaboration to evaluate a novel combination therapy using Imugene's onCARlytics (CF33-CD19) oncolytic virus and JW's CD19 CAR-T cell therapy, Carteyva®, in refractory solid tumors. * The collaboration includes precli...

2025-11-28 13:00 1128

JMGO Advances North American Market Strategy Through New Presence on Costco

SHENZHEN, China, Nov. 27, 2025 /PRNewswire/ -- JMGO, a pioneer in optical technology, announced its official cooperation with Costco in North America. Currently, JMGO has entered Costco Canada and will enter CostcoUSA by the end of this year, marking a major milestone in the company's North Ameri...

2025-11-28 12:46 991

Weihai Emerges as Sought-After Destination Wedding City

BEIJING, Nov. 28, 2025 /PRNewswire/ -- A news report from CRI Online: As sapphire seas and skies become the backdrop for "I dos" and cityscapes blend into sweet ceremonies, destination weddings are emerging as a new trend among young couples. Leveraging its exceptional coastal scenery and unique ...

2025-11-28 12:35 819

Weihai Launches Pioneering Reforms for Business Name Registration

BEIJING, Nov. 28, 2025 /PRNewswire/ --‌ A news report from CRI Online: Weihai has introduced two new regulatory documents: the "Weihai Guidelines for Enterprise Name Registration Management" and the "Weihai Implementation Rules for Enterprise Name Dispute Resolution." These measures mark a signi...

2025-11-28 12:32 757

The Annals of Oncology Publishes Results of Phase II Study of Sacituzumab Tirumotecan Monotherapy for Urothelial Carcinoma

CHENGDU, China, Nov. 28, 2025 /PRNewswire/ -- Recently, Clinical study results from Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990)'s TROP2 ADC sacituzumab tirumotecan (sac-TMT) monotherapy for advanced or metastatic urothelial carcinoma (UC) patients has been publ...

2025-11-28 12:32 998
1 ... 14151617181920 ... 1713

Week's Top Stories